Financial Performance - The company achieved total operating revenue of RMB 18,206,911.92 million, an increase of 3.83% compared to the previous year[3] - Net profit attributable to shareholders decreased by 22.49% to RMB 1,303,306.66 million compared to the previous year[4] - Basic earnings per share decreased by 22.57% to RMB 4.15[2] Assets and Equity - Total assets at the end of the reporting period reached RMB 29,333,334.97 million, reflecting a growth of 15.92% from the beginning of the period[4] - Shareholders' equity attributable to the company increased by 6.73% to RMB 9,462,589.61 million[4] Operational Developments - The company continued to enhance its global channel layout and improve the autonomous operation level of its facilities[4] - Sales volume and revenue of major products maintained a growth trend, despite a decline in trade revenue[4] Investment and Expenses - Research and development investment continued to increase, along with sales, management, and financial expenses[4] Risk and Stability - The overall gross profit remained stable year-on-year due to market price and raw material cost fluctuations[4] - The company issued a risk warning regarding the preliminary nature of the financial data, which has not been audited[2]
万华化学(600309) - 2024 Q4 - 年度业绩